Evidence map›Paper›PMID 11784857›Full record

ArticleMolecular and cellular biology2002

Removal of a single alpha-tubulin gene intron suppresses cell cycle arrest phenotypes of splicing factor mutations in Saccharomyces cerevisiae.

C Geoffrey Burns, Ryoma Ohi, Sapna Mehta, Eileen T O'Toole, Mark Winey, Tyson A Clark, Charles W Sugnet, Manuel Ares, Kathleen L Gould

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Isolation of mutant alleles of the U6 snRNA mmicroPublication biology · 2023
    Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Differential expression and alternative splicing of cell cycle genes in imatinib-treated K562 cells.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

C Geoffrey BurnsHoward Hughes Medical Institute, Department of Cell Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.
Ryoma Ohi
Sapna Mehta
Eileen T O'Toole
Mark Winey
Tyson A Clark
Charles W Sugnet
Manuel Ares
Kathleen L Gould
University of California, Santa Cruz · USHoward Hughes Medical Institute · USVanderbilt University · USUniversity of Colorado Boulder · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
MECHANISMS OF EUKARYOTIC CELL CYCLE CONTROLR01GM047728 · NIGMS · VANDERBILT UNIVERSITY · PI GOULD, KATHLEEN L · 1992 to 2004
$989k
NIGMS NIH HHS GM07347NIGMS NIH HHS GM47728NIGMS NIH HHS R01 GM047728NIGMS NIH HHS T32 GM007347
6 · The paper itself

Abstract

Genetic and biochemical studies of Schizosaccharomyces pombe and Saccharomyces cerevisiae have identified gene products that play essential functions in both pre-mRNA splicing and cell cycle control. Among these are the conserved, Myb-related CDC5 (also known as Cef1p in S. cerevisiae) proteins. The mechanism by which loss of CDC5/Cef1p function causes both splicing and cell cycle defects has been unclear. Here we provide evidence that cell cycle arrest in a new temperature-sensitive CEF1 mutant, cef1-13, is an indirect consequence of defects in pre-mRNA splicing. Although cef1-13 cells harbor global defects in pre-mRNA splicing discovered through intron microarray analysis, inefficient splicing of the alpha-tubulin-encoding TUB1 mRNA was considered as a potential cause of the cef1-13 cell cycle arrest because cef1-13 cells arrest uniformly at G(2)/M with many hallmarks of a defective microtubule cytoskeleton. Consistent with this possibility, cef1-13 cells possess reduced levels of total TUB1 mRNA and alpha-tubulin protein. Removing the intron from TUB1 in cef1-13 cells boosts TUB1 mRNA and alpha-tubulin expression to near wild-type levels and restores microtubule stability in the cef1-13 mutant. As a result, cef1-13 tub1Deltai cells progress through mitosis and their cell cycle arrest phenotype is alleviated. Removing the TUB1 intron from two other splicing mutants that arrest at G(2)/M, prp17Delta and prp22-1 strains, permits nuclear division, but suppression of the cell cycle block is less efficient. Our data raise the possibility that although cell cycle arrest phenotypes in prp mutants can be explained by defects in pre-mRNA splicing, the transcript(s) whose inefficient splicing contributes to cell cycle arrest is likely to be prp mutant dependent.

Indexed as

DNA-Binding ProteinsGenes, FungalRNA-Binding ProteinsRNA HelicasesBase SequenceCell CycleCell Cycle ProteinsDEAD-box RNA HelicasesDNA, FungalFungal ProteinsIntronsMicrotubulesMitosisMutationPhenotypeProtein KinasesCDC40 protein, S cerevisiaeCDC5 protein, S cerevisiaecdc5 protein, S pombeCEF1 protein, S cerevisiaeCell Cycle ProteinsDEAD-box RNA HelicasesDNA-Binding ProteinsDNA, FungalFungal ProteinsProtein KinasesProtein Serine-Threonine KinasesPRP22 protein, S cerevisiaeRNA-Binding ProteinsRNA, FungalRNA HelicasesRNA, MessengerRNA PrecursorsRNA Splicing FactorsSaccharomyces cerevisiae ProteinsSchizosaccharomyces pombe ProteinsTubulin

Identifiers

PMID11784857
PMCPMC133559
OpenAlexW2145948347

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.